Medical Research
(H46Z)
IRS Verified
DX Registered
SCLERODERMA RESEARCH FOUNDATION
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of the Scleroderma Research Foundation (SRF) is to fund and facilitate the most promising, highest quality research aimed at improved therapies and, ultimately, a cure for scleroderma.
Financial Overview — FY 2023
$8.4M
Total Revenue
$6.5M
Total Expenses
N/A
Net Assets
9
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$205K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $8.4M | $6.5M | N/A | — | 9 |
| 2022 | $5.9M | $4.7M | N/A | — | 6 |
| 2021 | $3.8M | $3.7M | N/A | — | 5 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.